MedPath

A Clinical study to evaluate efficacy of Patoladi Gana ghrita Pichu & Yashtimadhu ghrita Pichu in the management of Parikartika W.S.R.to Acute Fissure in Ano

Phase 2/3
Not yet recruiting
Conditions
Acute anal fissure. Ayurveda Condition: PARIKARTIKA,
Registration Number
CTRI/2023/11/060201
Lead Sponsor
Loknete Rajarambapu Patil Ayurvedic college and PG institute
Brief Summary

It is randomised, controlled clinical trial.it will be assess the efficacy of Patoladi Gana Ghrita pichu & Yashtimadhu Ghrita pichu in the management of Parikartika (Acute Fissure in Ano).

Trial will be conduced on patients having symptoms of Parikartika to assess the effects of two ghrita in relife of symptoms of Parikartika.The duration of tretement will be 15 days. Primary endpoint will be relife in symptoms like Guda Shool,Gudadaha,Guda Kandu,Raktasrava,Malavshathmbha etc.Secondary endpoint will be reduction in size of fissure and sphincter spasm.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
224
Inclusion Criteria

Patients suffering from Parikartika with symptoms of painful defecation burning sensation bleeding per rectum.

Exclusion Criteria

Patients having Chronic fissure in ano ArshaBhagandar Gudagat Arbud Gudvidradhi Diabetes Mellitus HIV Hepatitis B Coagulopathies Bleeding Disorders Anaemia etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
relife from symptoms like Guda Shoola, GudaDaha, Guda kandu, Raktasrava, MalavshthmbhaOn 0 5 10 & 15 days
Secondary Outcome Measures
NameTimeMethod
relife from sign like Vrana Size ,Assesement of Sphincter spasmon 22 & 29 day

Trial Locations

Locations (1)

Loknete Rajarambapu Patil Ayurvedic college Hospital Islampur

🇮🇳

Sangli, MAHARASHTRA, India

Loknete Rajarambapu Patil Ayurvedic college Hospital Islampur
🇮🇳Sangli, MAHARASHTRA, India
Dr Manisha Kashinath Bachhav
Principal investigator
7058843346
sushrut2217@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.